Oliver Königsbrügge, MD PhD

Physician
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna
Vienna, Wien, Austria

MD PhD at Medical Unversity of Vienna, Department of Internal Medicine, Clinical Division of Hematology and Hemostaseology.
My clinical work covers the full spectrum of malignant and benign hematology including hemostaseology.
My research focus lies on anticoagulation management in populations with high risk of thromboembolism and bleeding.
My second research focus lies in hemophilia treatment and care.

Presentation(s):

• PB0253 - Estimating the factor VIII-equivalent activity of emicizumab using global assays of hemostasis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 20.2 - Safety of factor XI inhibitors in patients with end-stage kidney disease on hemodialysis: A meta-analysis of randomized controlled trials

  Sunday, June 23, 2024
  15:00 – 15:15 ICT

• OC 27.2 - Comparing thrombin generation in hemophilia A and patients with non-valvular atrial fibrillation on vitamin K antagonists

  Sunday, June 23, 2024
  15:00 – 15:15 ICT

• PB1010 - Activated Partial Thromboplastin Time and Factor XI are associated with risk of bleeding in patients on hemodialysis

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1414 - Mitochondrial DNA copy number and the association with venous thromboembolism in patients with cancer

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT